Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 38Thoracic 6CNS 4Other solid neoplasm 3Sarcoma 2Head & Neck 2Gastrointestinal 2Endocrine 2NET 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Neuroendocrine Tumors 73Carcinoma, Neuroendocrine 27Pheochromocytoma 24Thyroid Cancer, Papillary 23Thyroid Neoplasms 21Pituitary Neoplasms 21Adrenocortical Carcinoma 19Paraganglioma 16Multiple Endocrine Neoplasia Type 1 14Neuroblastoma 12Sarcoma 11Adenoma, Islet Cell 11Small Cell Lung Carcinoma 10Neoplasms 10Melanoma 10Lung Neoplasms 9Carcinoid Tumor 9Adrenal Gland Neoplasms 9Adenocarcinoma, Follicular 9Pancreatic Neoplasms 8Gastro-enteropancreatic neuroendocrine tumor 8Carcinoma, Non-Small-Cell Lung 8Carcinoma, Medullary 8Thyroid Carcinoma, Anaplastic 7Neoplasm Metastasis 7Mesothelioma 7Cushing Syndrome 7Cholangiocarcinoma 7Central Nervous System Neoplasms 7Breast Neoplasms 7

Interventions

fludarabine phosphate 1Specimen Handling 1Magnetic Resonance Spectroscopy 1LY2940680 1Interleukin-13 1Fluorodeoxyglucose F18 1Cyclophosphamide 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uveal Melanoma × Endocrine × 90 days × Clear all
NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

NCT05199584 2026-03-05

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Endeavor Biomedicines, Inc.

Phase 2 Completed
20 enrolled
CNSDermatologicEndocrineHead & NeckOther solid neoplasmSarcomaThoracic

Uveal Melanoma, Glioma, Adenoma, Islet Cell, Laryngeal Diseases, Medulloblastoma, Melanoma, Mesothelioma, Neuroblastoma, Pituitary Diseases, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡